Short term effect of recombinant tissue plasminogen activator in patients with hemodynamically stable acute pulmonary embolism: Results of a meta-analysis involving 464 patients

Thrombosis Research

Volumn 124, Issue 6, 2009, Pages 672-677

  Tardy, B ^a   Venet, C ^a   Zeni, F ^a   Coudrot, M ^a   Guyomarc'h, S ^a   Mismetti, P ^b  

^a UNIVERSITY HOSPITAL OF SAINT ETIENNE   (France)

^b University Jean Monnet of Saint Etienne EA3065   (France)

Author keywords

heparin; pulmonary embolism; randomized controlled trial; thrombolysis; venous thromboembolism

Indexed keywords

ALTEPLASE; HEPARIN;

ARTICLE; BLEEDING; BLOOD CLOT LYSIS; BRAIN HEMORRHAGE; CARDIOGENIC SHOCK; CLINICAL TRIAL; CONVENTIONAL ANGIOGRAPHY; DEATH; DISEASE ASSOCIATION; DRUG DOSE ESCALATION; DRUG EFFICACY; DRUG FATALITY; ECHOGRAPHY; EMBOLECTOMY; FATALITY; FIBRINOLYTIC THERAPY; HEART RIGHT VENTRICLE FAILURE; HEMODYNAMIC PARAMETERS; HUMAN; LUNG EMBOLISM; LUNG HEMODYNAMICS; META ANALYSIS; MORTALITY; PERFORATION; PERICARDIAL EFFUSION; PRIORITY JOURNAL; RECURRENT DISEASE; RESPIRATORY DISTRESS; SYSTEMATIC REVIEW; TREATMENT OUTCOME; VENOUS THROMBOEMBOLISM;

ACUTE DISEASE; BIOLOGICAL MARKERS; DATABASES, FACTUAL; HEMODYNAMICS; HUMANS; PULMONARY EMBOLISM; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RECOMBINANT PROTEINS; THROMBOLYTIC THERAPY; TREATMENT OUTCOME;

EID: 70449527714     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2009.05.009     Document Type: Article

References (32)

1. Kearon C., Kahn S.R., Agnelli G., Goldhaber S., Raskob G.E., and Comerota A.J. Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians. Evidenced-Based Clinical Practice Guidelines (8th Edition). Chest 133 (2008) 454S-545S
2. Torbicki A., Perrier A., Konstantinides S., Agnelli G., Galiè N., Pruszczyk P., et al. Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology. Guidelines on the diagnosis and management of acute pulmonary embolism: the Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC). Eur Heart J 29 (2008) 2276-2315
3. Agnelli G., Becattini C., and Kirschstein T. Thrombolysis vs heparin in the treatment of pulmonary embolism: a clinical outcome-based meta-analysis. Arch Intern Med 162 (2002) 2537-2541
4. Thabut G., Thabut D., Myers R.P., Bernard-Chabert B., Marrash-Chahla R., Mal H., et al. Thrombolytic therapy of pulmonary embolism: a meta-analysis. J Am Coll Cardiol 40 (2002) 1660-1667
5. Wan S., Quinlan D.J., Agnelli G., and Eikelboom J.W. Thrombolysis compared with heparin for the initial treatment of pulmonary embolism. Circulation 110 (2004) 744-749
6. Ribeiro A., Lindmarker P., Juhlin-Dannfelt A., Johnsson H., and Jorfeldt L. Echocardiography Doppler in pulmonary embolism: right ventricular dysfunction as a predictor of mortality rate. Am Heart J 134 (1997) 479-487
7. Grifoni S., Olivotto I., Cecchini P., Pieralli F., Camaiti A., Santoro G., et al. Short term clinical outcome of patients with acute pulmonary embolism, normal blood pressure, and echocardiographic right ventricular dysfuction. Circulation 101 (2000) 2817-2822
8. Konstantinides S., Geibel A., Olschewski M., Heinrich F., Grosser K., Rauber K., et al. Association between thrombolytic treatment and the prognosis of hemodynamically stable patients with major pulmonary embolism: results of a multicenter registry. Circulation 96 (1997) 882-888
9. Urokinase Pulmonary Embolism Trial Study Group. Urokinase pulmonary embolism trial: phase 1 results. JAMA 214 (1970) 2163-2172
10. Sharma G.V., Burleson V.A., and Sasahara A.A. Effects of thrombolytic therapy on pulmonary-capillary blood volume in patients with pulmonary embolism. N Engl J Med 303 (1980) 842-845
11. Sasahara A.A., Sharma G.V., Parisi A.F., Barsamian E.M., McIntyre K.M., Tow D.E., et al. Pulmonary embolism, pulmonary microcirculation, and thrombolytic therapy. Angiology 33 (1982) 368-374
12. Giuntini C., Marini C., Di Rocco G., Palla R., Giacomelli V., and Rindi M. A controlled clinical trial on the effects of heparin infusion and two regimens of urokinase in acute pulmonary embolism. G Ital Cardiol 14 suppl 1 (1984) 26-29
13. Palla A., Pazzagli M., Manganelli D., De Nitto P., Marini C., Rossi G., et al. Resolution of pulmonary embolism: effect of therapy and putative age of emboli. Respiration 64 (1997) 50-53
14. Sharma G.V., Folland E.D., McIntyre K.M., and Sasahara A.A. Long term benefit of thrombolytic therapy in patients with pulmonary embolism. Vasc Med 5 (2000) 91-95
15. The Urokinase Pulmonary Embolism Trial. A national cooperative study. Circulation 47 suppl 2 (1973) 1-108
16. Tibbutt D.A., Davies J.A., Anderson J.A., Fletcher E.W.L., Hamill J., Holt J.M., et al. Comparison by controlled clinical trial of streptokinase and heparin in treatment of life threatening pulmonary embolism. BMJ 1 (1974) 343-347
17. Ly B., Arnesen H., Eie H., and Hol R. A controlled clinical trial of streptokinase and heparin in the treatment of major pulmonary embolism. Acta Med Scand 203 (1978) 465-470
18. Dotter C.T., Seaman A.J., Rösch J., and Porter J.M. Streptokinase and heparin in the treatment of pulmonary embolism: a randomized comparison. Vasc Surg 13 (1979) 42-52
19. Marini C., Di Rocco G., Rossi G., Rindi M., Palla R., and Giuntini C. Fibrinolytic effects of urokinase and heparin in acute pulmonary embolism: a randomized clinical trial. Respiration 54 (1988) 162-173
20. Jerjes-Sanchez C., Ramirez-Riveroa A., de Lourdes Garcia M., Arriaga-Nava R., Valencia S., Rosado-Buzzo A., et al. Streptokinase and heparin versus heparin alone in massive pulmonary embolism: a randomized controlled trial. J Thromb Thrombolysis 2 (1995) 227-229
21. Cheng X., He J., Gao M., Chen G., Li S., Zhang Z., et al. Multicenter clinical trial on the efficacy of thrombolytic therapy with urokinase and/or anticoagulant with low molecular weight heparin in acute pulmonary embolism. Zhonghua Nei Ke ZA Zhi 41 (2002) 6-10
22. Levine M., Hirsh J., Weitz J., Cruickshank M., Neemeh J., Turpie A.G., et al. A randomized trial of a single bolus dosage regimen of recombinant tissue plasminogen activator in patients with pulmonary embolism. Chest 98 (1990) 1473-1479
23. PIOPED investigators. Tissue plasminogen activator for the treatment of acute pulmonary embolism: a collaborative study. Chest 97 (1990) 528-533
24. Dalla-Volta S., Palla A., Santolicandro A., Giuntini C., Pengo V., Visioli O., et al. PAIMS 2: alteplase combined with heparin versus heparin in the treatment of acute pulmonary embolism. Plasminogen Activator Italian Multicenter study 2. JACC 20 (1992) 520-526
25. Goldhaber S.Z., Haire W.D., Feldstein M.L., Miller M., Toltzis R., Smith J.L., et al. Alteplase versus heparin in acute pulmonary embolism: randomized trial assessing right ventricular function and pulmonary perfusion. Lancet 341 (1993) 507-511
26. Konstantinides S., GeiBel A., Heusel G., Heinrich F., and Kasper W. Heparin plus alteplase compared with heparin alone in patients with submassive pulmonary embolism. N Engl J Med 347 (2002) 1143-1150
27. The Matisse Investigators. Subcutaneous Fondaparinux versus unfractionated heparin in the initial treatment of pulmonary embolism. N Engl J Med 349 (2003) 1695-1702
28. Hamel E., Pacouret G., Vincentelli D., Forissier J.F., Peycher P., Pottier J.M., et al. Thrombolysis and heparin therapy in massive pulmonary embolism with right ventricular dilatation: results from a 128-patient monocenter registry. Chest 120 (2001) 120-125
29. Pruszcyk P., Bochowicz A., Kostrubiec M., Torbicki A., Szulc M., Gurba H., et al. Myoglobin stratifies short term risk in acute major pulmonary embolism. Clin Chim Acta 338 (2003) 53-56
30. Kucher N., Wallmann D., Carone A., Windecker S., Meier B., and Hess O.M. Incremental prognostic value of troponin I and echography in patients with acute pulmonary embolism. Eur Heart J 24 (2003) 1651-1656
31. Konstantinides S., Geibel A., Olschewski M., Kasper W., Hruska N., Jac S., et al. Importance of cardiac troponins I and T in risk stratification patients with acute pulmonary embolism. Circulation 106 (2002) 1263-1268
32. Ten Wolde M., Tulevski I.I., Mulder J.W.M., Söhne M., Boomsma F., Mulder B.J.M., et al. Brain natriuretic peptide as a predictor of adverse outcome in patients with pulmonary embolism. Circulation 107 (2003) 2082-2084